Neuropsychological tests for the diagnosis of Alzheimer's disease dementia and other dementias: A generic protocol for cross-sectional and delayed-verification studies

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 3, 2013, Pages

  Davis, Daniel H J ^a   Creavin, Sam T ^b   Noel Storr, Anna ^c   Quinn, Terry J ^d   Smailagic, Nadja ^e   Hyde, Chris ^f   Brayne, Carol ^a   Mcshane, Rupert ^c   Cullum, Sarah ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADDENBROOKE COGNITIVE EXAMINATION REVISED; ALZHEIMER DISEASE; ARTICLE; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIFFUSE LEWY BODY DISEASE; FRONTOTEMPORAL DEMENTIA; HUMAN; MINI COG TEST; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85040468487     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010460     Document Type: Article

References (49)

1. Alzheimer's Society. Dementia UK: A report into the prevalence and cost of dementia prepared by the Personal Social Services Research Unit (PSSRU) at the London School of Economics and the Institute of Psychiatry at King's College London, for the Alzheimer's Society. Alzheimer's Society, 2007.
2. Diagnostic and statistical manual of mental disorders (DSM-IV). Amercian Psychiatric Association. Washington DC: American Psychiatric Association, 1994.
3. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006;3:Art. No.: CD005593.
4. Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The Mini-Cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. International Journal of Geriatric Psychiatry 2000;15:1021-7.
5. Bourne J. Improving services and support for people with dementia. National Audit Office, . UK, 2007.
6. Boustani M, Peterson B, Hanson L, Harris R, Lohr KN. Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2003;138:927-37.
7. Brown J, Pengas G, Dawson K, Brown LA, Clatworthy P. Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study. BMJ 2009;338:b2030.
8. Bruscoli M, Lovestone S. Is MCI really just early dementia? A systematic review of conversion studies. International Psychogeriatrics 2004;16:129-40.
9. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
10. Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2003;4:CD003260.
11. Crawford S, Whitnall L, Robertson J, Evans JJ. A systematic review of the accuracy and clinical utility of the Addenbrooke's Cognitive Examination and the Addenbrooke's Cognitive Examination-Revised, in the diagnosis of dementia. International Journal of Geriatric Psychiatry 2012;27:659-69.
12. de Silva V, Hanwella R. Why are we copyrighting science?. BMJ 2010;341:c4738.
13. Macaskill P, Gatsonis C, Deeks JJ, Harbord R, Yemisi Takwoingi Y. Chapter 10: Analysing and presenting results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter%2010%20-%20Version%201.0.pdf. The Cochrane Collaboration, 2010.
14. Smidt N, Deeks J, Moore T. Chapter 4: Guide to the contents of a Cochrane review and protocol. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Handbook1CC_Chapter04_101.pdf. The Cochrane Collaboration, 2010.
15. Bossuyt PM, Leeflang MM. Chapter 6: Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter06-Including-Studies%20%28September-2008%29.pdf. The Cochrane Collaboration, 2008.
16. de Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D. Chapter 7: Searching for Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/Chapter07-Searching-%28September-2008%29.pdf. The Cochrane Collaboration, 2008.
17. Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Chapter 9: Assessing methodological quality. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/ch09_Oct09.pdf. The Cochrane Collaboration, 2009.
18. Ferri C P, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al.Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7.
19. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State - Practical method for grading cognitive state of patients for clinicians. Journal of Psychiatric Research 1975;12:189-98.
20. Glanville JM, Cikalo M, Crawford F, Dozier M, McIntosh H. Handsearching did not yield additional unique FDG-PET diagnostic test accuracy studies compared with electronic searches: a preliminary investigation. Research Synthesis Methods September 2012;3(3):202-13.
21. Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. International Journal of Geriatric Psychiatry 2010;25:111-20.
22. Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al.Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:257-62.
23. Leeflang MM, Moons KG, Reitsma JB, Zwinderman AH. Bias in sensitivity and specificity caused by data-driven selection of optimal cutoff values: mechanisms, magnitude, and solutions. Clinical Chemistry 2008;54:729-37.
24. Luengo-Fernandez R, Leal J, Gray AM. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?. European Journal of Neurology 2012;19:149-54.
25. The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57:416-8.
26. Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society 2008;56:1424-33.
27. Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6:e1000180.
28. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al.Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International workshop. Neurology 1996;47:1113-24.
29. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al.Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-72.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
31. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
32. McShane R, Areosa Sastre A, Minakaran N. Memantine for dementia. Cochrane Database of Systematic Reviews 2006;3:CD003154.
33. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry 2006;21:1078-85.
34. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al.The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
35. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica 2009;119:252-65.
36. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al.The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005;53:695-9.
37. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Journal of Neuropathology and Experimental Neurology 1999;58:1147-55.
38. Dementia: supporting people with dementia and their careers in health and social care. National Institute for Health and Clinical Excellence 2006; Vol. Clinical Guideline 42.
39. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999;56:303-8.
40. Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004;256:183-94.
41. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology 2005;58:982-90.
42. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al.Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
43. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. New England Journal of Medicine 2009;360:2302-9.
44. Scheltens P, Rockwood K. How golden is the gold standard of neuropathology in dementia?. Alzheimer's & Dementia 2011;7:486-9.
45. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al.QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529-36.
46. Whiting P, Westwood M, Beynon R, Burke M, Sterne J A, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64:602-7.
47. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva, Switzerland: WHO, . Geneva: World Health Organization, 1992.
48. Wimo A, Prince M. World Alzheimer's Report 2010: the global economic impact of dementia. London, UK: Alzheimer's Disease International (ADI), . London, UK, 2010.
49. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al.Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004;256:240-6.